A型肉毒毒素注射治疗脑卒中后上肢痉挛的运动学改善。
Kinematic improvement following Botulinum Toxin-A injection in upper-limb spasticity due to stroke.
机构信息
Neurorehabilitation Section and Spasticity Clinic, Neurology Department, Institute for Neurological Research, FLENI, Montaneses 2325, Buenos Aires C1428AQK, Argentina.
出版信息
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):423-7. doi: 10.1136/jnnp.2009.188052. Epub 2009 Dec 3.
Abstract
Background Focal spasticity is a significant motor disorder following stroke, and Botulinum Toxin Type-A (BoNT-A) is a useful treatment for this. The authors evaluated kinematic modifications induced by spasticity, and whether or not there is any improvement following injection of BoNT-A. Methods Eight patients with stroke with upper-limb spasticity, showing a flexor pattern, were evaluated using kinematics before and after focal treatment with BoNT-A. A group of sex- and age-matched normal volunteers acted as a control group. Results Repeated-measures ANOVA showed that patients with stroke performed more slowly than the control group. Following treatment with BoNT-A, there was a significant improvement in kinematics in patients with stroke, while in the control group, performance remained unchanged. Conclusions Focal treatment of spasticity with BoNT-A leads to an adaptive change in the upper limb of patients with spastic stroke.
摘要
背景 局灶性痉挛是中风后的一种严重运动障碍，肉毒毒素 A 型（BoNT-A）是一种有效的治疗方法。作者评估了痉挛引起的运动学改变，以及 BoNT-A 注射后是否有任何改善。
方法 8 例上肢痉挛呈屈肌模式的中风患者，在接受 BoNT-A 局灶治疗前后进行运动学评估。一组性别和年龄匹配的正常志愿者作为对照组。
结果 重复测量方差分析显示，中风患者的运动速度比对照组慢。BoNT-A 治疗后，中风患者的运动学有显著改善，而对照组的表现保持不变。
结论 BoNT-A 局灶性治疗痉挛可导致痉挛性中风患者上肢的适应性改变。
相似文献
1
Kinematic improvement following Botulinum Toxin-A injection in upper-limb spasticity due to stroke.A型肉毒毒素注射治疗脑卒中后上肢痉挛的运动学改善。
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):423-7. doi: 10.1136/jnnp.2009.188052. Epub 2009 Dec 3.
2
Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.采用 Euro-musculus 方法评估超声引导肉毒毒素 A 注射治疗脑卒中后上肢痉挛患者的功能结局：一项观察性研究。
Eur J Phys Rehabil Med. 2018 Oct;54(5):738-744. doi: 10.23736/S1973-9087.18.05086-4. Epub 2018 Feb 7.
3
Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.A型肉毒毒素治疗小儿脑瘫上下肢痉挛的有效性：证据总结
J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14.
4
Multidimensional evaluation of changes in limb function following botulinum toxin injection in persons with stroke.脑卒中患者接受肉毒毒素注射后肢体功能变化的多维评估。
NeuroRehabilitation. 2019;45(1):67-78. doi: 10.3233/NRE-192722.
5
Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.A型肉毒毒素治疗中风或创伤性脑损伤后上肢痉挛的疗效和安全性：一项系统评价及荟萃分析和试验序贯分析
Eur J Phys Rehabil Med. 2017 Apr;53(2):256-267. doi: 10.23736/S1973-9087.16.04329-X. Epub 2016 Nov 11.
6
Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.我们是否低估了A型肉毒杆菌毒素的临床疗效？量化单侧中风患者肘部屈肌注射肉毒杆菌毒素后痉挛、力量和上肢功能的变化。
Clin Rehabil. 2002 Sep;16(6):654-60. doi: 10.1191/0269215502cr536oa.
7
The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.肉毒毒素在增强中风后患者目标实现中的复杂作用。
Toxins (Basel). 2024 Mar 31;16(4):172. doi: 10.3390/toxins16040172.
8
Botulinum toxin type A for upper limb spasticity after stroke.A型肉毒毒素治疗脑卒中后上肢痉挛。
Expert Rev Neurother. 2009 Dec;9(12):1713-25. doi: 10.1586/ern.09.121.
9
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.A型肉毒毒素注射后，黏贴式绷带与每日手动肌肉拉伸及夹板固定对中风患者手腕和手指痉挛性过度活动的影响：一项随机对照试验
Clin Rehabil. 2015 Jan;29(1):50-8. doi: 10.1177/0269215514537915. Epub 2014 Jun 10.
10
Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.脑卒后 12 周内上肢痉挛患者接受肉毒毒素注射治疗的随机对照试验。
Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824. Epub 2012 Feb 27.
引用本文的文献
1
Botulinum Toxin A for Elbow Flexor Spasticity: A Non-Randomized Observational Study of Muscle-Specific Injection Strategies.用于肘部屈肌痉挛的A型肉毒毒素：肌肉特异性注射策略的非随机观察性研究
J Clin Med. 2025 May 30;14(11):3864. doi: 10.3390/jcm14113864.
2
Investigation of the Kinematic Upper-Limb Movement Assessment (KUMA): A Pilot Study.运动学上肢运动评估（KUMA）的研究：一项初步研究。
Physiother Can. 2022 Jul 8;74(3):316-323. doi: 10.3138/ptc-2019-0023. eCollection 2022 Aug.
3
The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.肉毒毒素注射对慢性脑卒中痉挛性偏瘫患者的痉挛和运动功能的影响。
Toxins (Basel). 2020 Jul 31;12(8):492. doi: 10.3390/toxins12080492.
4
The Use of Botulinum Toxin for Treatment of Spasticity.肉毒杆菌毒素在痉挛治疗中的应用。
Handb Exp Pharmacol. 2021;263:127-146. doi: 10.1007/164_2019_315.
5
Combining Upper Limb Robotic Rehabilitation with Other Therapeutic Approaches after Stroke: Current Status, Rationale, and Challenges.上肢机器人康复与中风后其他治疗方法相结合：现状、原理和挑战。
Biomed Res Int. 2017;2017:8905637. doi: 10.1155/2017/8905637. Epub 2017 Sep 13.
6
Therapeutic use of botulinum toxin in neurorehabilitation.肉毒杆菌毒素在神经康复中的治疗应用。
J Toxicol. 2012;2012:802893. doi: 10.1155/2012/802893. Epub 2011 Sep 14.
本文引用的文献
1
Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.肉毒杆菌神经毒素与替扎尼定治疗上肢痉挛的比较：一项安慰剂对照研究。
J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):380-5. doi: 10.1136/jnnp.2008.159657. Epub 2008 Oct 31.
2
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.评估：肉毒杆菌神经毒素治疗痉挛（基于证据的综述）：美国神经病学学会治疗与技术评估小组委员会报告
Neurology. 2008 May 6;70(19):1691-8. doi: 10.1212/01.wnl.0000311391.00944.c4.
3
What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2?在中风试验中，什么应被定义为良好的结果；改良Rankin量表评分为0 - 1还是0 - 2？
J Neurol. 2008 Jun;255(6):867-74. doi: 10.1007/s00415-008-0796-8. Epub 2008 Mar 14.
4
Kinematic aiming task: measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia.运动学瞄准任务：测量痉挛性偏瘫患儿注射A型肉毒毒素后手部和手臂运动的功能变化。
Am J Phys Med Rehabil. 2007 Jul;86(7):538-47. doi: 10.1097/PHM.0b013e31806dbc3c.
5
The spinal pathophysiology of spasticity--from a basic science point of view.从基础科学角度看痉挛的脊髓病理生理学
Acta Physiol (Oxf). 2007 Feb;189(2):171-80. doi: 10.1111/j.1748-1716.2006.01652.x.
6
Weakness is the primary contributor to finger impairment in chronic stroke.虚弱是慢性中风手指功能障碍的主要促成因素。
Arch Phys Med Rehabil. 2006 Sep;87(9):1262-9. doi: 10.1016/j.apmr.2006.05.013.
7
Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke.重复注射A型肉毒杆菌毒素治疗中风后上肢痉挛
Neurology. 2004 Nov 23;63(10):1971-3. doi: 10.1212/01.wnl.0000144349.95487.91.
8
Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review.非进行性神经疾病中的口服抗痉挛药物：一项系统评价
Neurology. 2004 Oct 26;63(8):1357-63. doi: 10.1212/01.wnl.0000141863.52691.44.
9
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.降低痉挛状态是否能转化为功能上的益处？一项探索性荟萃分析。
J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1547-51. doi: 10.1136/jnnp.2003.025551.
10
Reorganization of the human ipsilesional premotor cortex after stroke.中风后人患侧运动前区皮质的重组
Brain. 2004 Apr;127(Pt 4):747-58. doi: 10.1093/brain/awh082. Epub 2004 Jan 28.
Zotero 插件